The Spanish government seems willing to encourage foreign investment in R+D. It would not be a bad strategy since the R+D expenditures of Spanish companies is quite low, but experts say Spain must undertake major reforms to attract foreign investment

XAVIER PUJOL GEBELLÍ | DECEMBER 16TH, 2010

The marketing malpractice of Wyeth has been exposed after the publication of a complete analysis of how this drug maker sold menopausal hormone therapy under false claims. It has been proven that the company commissioned and managed to publish articles in medical journals that promoted the unproven benefits of the drug and concealed or minimized the risks associated with breast cancer.

MALÉN RUIZ DE ELVIRA | SEPTEMBER 21ST, 2010

The United States currently leads the investment in transforming the current energy model. But it is not the only protagonist. Europe, with the help of the European Institute of Innovation and Technology, aims to encourage communities to reunite higher education and enterprises with the double objective of improving the science of climate change and get benefit in the form of innovations in the energy sector.

Xavier Pujol Gebellí | 18 March 2010

It is not easy to hit with the recipe of innovation, and much less in times of crisis like the current ones. But to maintain the flag of R&D high for the ones living on millionaire sales, it is mainly an obligation, if one wants to preserve a privileged position for the future, to not depend on the bad numbers of a few exercises. It is with high investment percentages in the generating of knowledge and its transformation in product, technology or services; that the great companies are facing bad times. Something like harvesting today for collecting tomorrow.

Xavier Pujol Gebellí | Ludwigshafen | 4 February 2010